EA006439B1 - Пероральная пищевая добавка для лечения хронических изнуряющих заболеваний - Google Patents

Пероральная пищевая добавка для лечения хронических изнуряющих заболеваний Download PDF

Info

Publication number
EA006439B1
EA006439B1 EA200400291A EA200400291A EA006439B1 EA 006439 B1 EA006439 B1 EA 006439B1 EA 200400291 A EA200400291 A EA 200400291A EA 200400291 A EA200400291 A EA 200400291A EA 006439 B1 EA006439 B1 EA 006439B1
Authority
EA
Eurasian Patent Office
Prior art keywords
sod
component
nutritional supplement
supplement according
coenzyme
Prior art date
Application number
EA200400291A
Other languages
English (en)
Russian (ru)
Other versions
EA200400291A1 (ru
Inventor
Карл Джермано
Original Assignee
Милленниум Биотекнолоджиз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Милленниум Биотекнолоджиз, Инк. filed Critical Милленниум Биотекнолоджиз, Инк.
Publication of EA200400291A1 publication Critical patent/EA200400291A1/ru
Publication of EA006439B1 publication Critical patent/EA006439B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
EA200400291A 2001-08-10 2002-08-09 Пероральная пищевая добавка для лечения хронических изнуряющих заболеваний EA006439B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/927,174 US6503506B1 (en) 2001-08-10 2001-08-10 Nutrient therapy for immuno-compromised patients
PCT/US2002/025358 WO2003013438A2 (en) 2001-08-10 2002-08-09 Nutrient therapy for immuno-compromised patients

Publications (2)

Publication Number Publication Date
EA200400291A1 EA200400291A1 (ru) 2004-08-26
EA006439B1 true EA006439B1 (ru) 2005-12-29

Family

ID=25454328

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400291A EA006439B1 (ru) 2001-08-10 2002-08-09 Пероральная пищевая добавка для лечения хронических изнуряющих заболеваний

Country Status (9)

Country Link
US (1) US6503506B1 (cg-RX-API-DMAC7.html)
EP (1) EP1432436A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005501061A (cg-RX-API-DMAC7.html)
CN (1) CN1568196A (cg-RX-API-DMAC7.html)
AP (1) AP2004002994A0 (cg-RX-API-DMAC7.html)
CA (1) CA2457624A1 (cg-RX-API-DMAC7.html)
EA (1) EA006439B1 (cg-RX-API-DMAC7.html)
OA (1) OA12649A (cg-RX-API-DMAC7.html)
WO (1) WO2003013438A2 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2656544C1 (ru) * 2017-07-07 2018-06-05 Общество с ограниченной ответственностью "Академия-Т" Функциональный продукт питания для коррекции психофизиологического состояния и нейромышечной передачи у спортсменов

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6616942B1 (en) 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
WO2005032278A1 (en) 2003-09-29 2005-04-14 Soft Gel Technologies, Inc. SOLUBILIZED CoQ-10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
ITTO20030789A1 (it) * 2003-10-07 2005-04-08 Professional Dietetics Srl Composizione a base di amino acidi per il trattamento
ES2677868T3 (es) * 2003-10-16 2018-08-07 Nestec S.A. Composición nutricional frente a los efectos secundarios de la quimioterapia o de la radioterapia
HRP20130459T1 (en) 2004-01-22 2013-06-30 University Of Miami Topical co-enzyme q10 formulations and methods of use
KR20060132667A (ko) * 2004-01-28 2006-12-21 네스텍소시에테아노님 피부 상태 개선 및 피부 질환 예방을 위한 영양 조성물
US20050209170A1 (en) * 2004-03-18 2005-09-22 Takemoto Arnold C Breast health preparations
EP1734978A2 (en) * 2004-03-17 2006-12-27 Arnold C. Takemoto Tissue detoxification and health supplements and methods of making and using them
JP2005336176A (ja) * 2004-04-28 2005-12-08 Tanabe Seiyaku Co Ltd 肉体疲労改善剤
EP1600061B1 (en) * 2004-05-25 2010-05-12 Cognis IP Management GmbH Oral and/or topical compositions
US20050265990A1 (en) * 2004-06-01 2005-12-01 Shawn Talbott Treatments and nutritional supplements for assisting post-exercise recovery
JP5069000B2 (ja) * 2004-06-30 2012-11-07 敦生 関山 非炎症性ストレス応答の指標剤およびその利用
KR100584891B1 (ko) 2004-08-13 2006-05-30 (주)씨스팜 경구용 슈퍼옥사이드 디스뮤타제 제제인, 캔털루프 멜론추출물과 글리아딘 결합물을 숙취해소에 사용하는 방법
US7284385B2 (en) * 2004-09-16 2007-10-23 Hess Spencer W Pre-dried air reactivation for diesel fuel heated dessicant reactivator
JP5040060B2 (ja) * 2004-10-14 2012-10-03 大正製薬株式会社 メチオニン配合内服液剤
US20060147550A1 (en) * 2004-12-30 2006-07-06 Gorsek Wayne F Immune system enhancement and stimulation formulation
US20070114476A1 (en) * 2005-11-04 2007-05-24 Williams Christopher P Low radiocarbon nucleotide and amino acid dietary supplements
CN101316582A (zh) * 2005-11-30 2008-12-03 雀巢技术公司 治疗肌肉损失的方法
WO2007077995A1 (ja) * 2006-01-05 2007-07-12 Kyowa Hakko Kogyo Co., Ltd. 筋肉増量剤
GB0603975D0 (en) * 2006-03-01 2006-04-05 Etren Methods and agents for reducing oxidative stress
CN101420973A (zh) * 2006-03-15 2009-04-29 埃索谢尔制药公司 包含SODs和基于谷醇溶蛋白的肽片段的药物组份
FR2899065B1 (fr) * 2006-03-29 2008-07-18 Alain Dreyer Brevets Et Dev So Sod micro encapsulee et adsorbee sur support mineral et vegetal destinee a l'alimentation animale
DE102006046960A1 (de) * 2006-10-04 2008-04-10 Euro Allianz Pharma Gmbh Gesundheitsfördernde Nahrungsmittelzusammensetzung
US20080119386A1 (en) * 2006-11-22 2008-05-22 Carl Germano Nutritional formula for athletes' recovery
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
EP2158462A4 (en) 2007-05-03 2010-05-05 Radiocarb Genetics Inc FOOD SUPPLEMENTS WITH LITTLE RADIO CARBON AND MANUFACTURING METHOD THEREFOR
ES2675942T3 (es) * 2007-09-27 2018-07-13 Biothera, Inc. Tratamiento con B-glucano de síntomas de infección del tracto respiratorio superior y del bienestar psicológico
WO2009099444A1 (en) * 2008-02-08 2009-08-13 Millennium Biotechnologies, Inc. Nutritional formula for athletes' recovery
JP6058263B2 (ja) 2008-04-11 2017-01-11 バーグ リミテッド ライアビリティ カンパニー 癌細胞においてアポトーシスを誘導する方法および使用
WO2010053854A1 (en) * 2008-11-06 2010-05-14 Altman Enterprises Llc Medication and treatment for disease
CN102481269B (zh) 2009-05-11 2015-10-07 博格有限责任公司 包含辅酶q10的药物组合物及其制备方法
EP2311449A1 (de) * 2009-10-14 2011-04-20 NÖM Aktiengesellschaft Oral verabreichbare nahrungsergänzende Zusammensetzung enthaltend Carnitin
CN113142581B (zh) 2010-12-23 2025-07-22 阿马曾提斯公司 用于改善线粒体功能的组合物和方法
WO2012097061A1 (en) * 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for improving skeletal muscle protein metabolism
US9198881B2 (en) 2011-01-18 2015-12-01 Stephen T. Sinatra Equine nutritional supplement
JP6092844B2 (ja) 2011-04-04 2017-03-08 バーグ エルエルシー 中枢神経系腫瘍の治療方法
BR112015025424A2 (pt) 2013-04-08 2017-07-18 Berg Llc tratamento de câncer usando terapias de combinação de coenzima q10
MX381399B (es) 2013-09-04 2025-03-12 Berg Llc Formulaciones de coenzima q10 y métodos de uso.
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
CN105709212A (zh) * 2016-01-29 2016-06-29 周瑞华 一种免疫平衡调节剂及其制备方法和应用
CA3109188A1 (en) * 2018-08-10 2020-02-13 Maine Natural Health Company, Inc. Comestible compositions for promoting atp synthesis
CN110664824B (zh) * 2019-08-09 2021-01-01 北京佳博泰和健康科技有限公司 一种营养支持剂及其制备方法和用途
CN111820330A (zh) * 2020-07-17 2020-10-27 禹城保立康生物饲料有限公司 一种提高哺乳仔猪发育的母猪饲料
GB202308224D0 (en) 2023-06-01 2023-07-19 Amazentis Sa Formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456924A (en) * 1988-12-23 1995-10-10 Immunotec Research Corporation Ltd. Method of treatment of HIV-seropositive individuals with dietary whey proteins
IT1258491B (it) * 1992-09-24 1996-02-26 Sigma Tau Ind Farmaceuti Impiego di l-carnitina e acil l-carnitine nel trattamento di pazienti affetti da aids e sindromi correlate e di pazienti asintomatici hiv- sieropositivi.
FR2729296B1 (fr) 1995-01-12 1997-03-28 Europlanaire Compositions pharmaceutiques comprenant une superoxyde dismutase
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
US6503506B1 (en) * 2001-08-10 2003-01-07 Millenium Biotechnologies, Inc. Nutrient therapy for immuno-compromised patients

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2656544C1 (ru) * 2017-07-07 2018-06-05 Общество с ограниченной ответственностью "Академия-Т" Функциональный продукт питания для коррекции психофизиологического состояния и нейромышечной передачи у спортсменов

Also Published As

Publication number Publication date
EP1432436A2 (en) 2004-06-30
EA200400291A1 (ru) 2004-08-26
AP2004002994A0 (en) 2004-03-31
OA12649A (en) 2006-06-16
CA2457624A1 (en) 2003-02-20
WO2003013438A2 (en) 2003-02-20
US6503506B1 (en) 2003-01-07
JP2005501061A (ja) 2005-01-13
CN1568196A (zh) 2005-01-19
WO2003013438A3 (en) 2003-06-19
EP1432436A4 (en) 2005-02-09

Similar Documents

Publication Publication Date Title
US6503506B1 (en) Nutrient therapy for immuno-compromised patients
EP1455603B1 (en) Stimulation of in vivo production of proteins with formulation comprising leucine
RU2356247C2 (ru) Комбинации и композиции, содержащие жирные кислоты и аминокислоты, их применение для предупреждения, замедления прогрессирования или лечения диабета и связанных с диабетом заболеваний и состояний, способ снижения веса тела млекопитающего, набор
US6713082B2 (en) Composition comprising carbohydrate and peptide material and its use as an energy supplement after or during physical exercise or as a metabolic nutrient for oral consumption
ES2314692T3 (es) Composiciones nutricionales y metodos para tratar o prevenir la osteoporosis.
US20010041187A1 (en) Performance-enhancing dietary supplement
CN103945711B (zh) 对抗肌萎缩和少肌症的乳清蛋白胶束
JP2006503105A (ja) ロイシンに富んだ栄養的組成物
BR112015000136B1 (pt) fibra alimentar para uso no tratamento de um efeito colateral gastrintestinal de uma nutrição ou medicamento
WO2004000042A2 (en) Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
US20200155589A1 (en) Composition For Enchanced Recovery After Surgery (ERAS)
US9956255B1 (en) Method to reduce body weight, fat accumulation and adipocyte size using Parabacteroides goldsteinii
WO2011096413A1 (ja) 運動機能改善剤
ES2743955T3 (es) Composiciones que comprenden cinamaldehído y zinc y métodos para utilizar tales composiciones
WO2010107307A1 (en) Kit of parts comprising l-glutamine and egcg
Parate Vishal et al. Food fortification of soy protein isolate for human health
CN1984571A (zh) 提高哺乳动物营养物利用的方法和其中使用的组合物
JP2009209088A (ja) アスペルロシドまたはその類縁体を含む筋肉増強剤
AU2002324659A1 (en) Nutrient therapy for immuno-compromised patients
Cribb Whey proteins and immunity
HK1073261A (en) Nutrient therapy for immuno-compromised patients
HK1065447B (en) Stimulation of in vivo production of proteins with formulation comprising leucine
EP3773013A1 (en) Insulin control in overweight or obese adult during life time intervention

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ RU